Swiss Medical Device Database is Under Construction
Swissmedic is in the process of developing a new database for registering economic operators and medical devices.
Due to the continuing aim of equivalence between regulation in Switzerland and the EU, the medical devices database will be similar to EUDAMED. The new medical devices database will include registration of economic operators and medical devices. It will be possible to register medical devices by mass upload.
Economic operators who are already registered with Swissmedic or who register before the introduction of the medical devices database (unique identification number, CHRN) will not have to re-register (data migration).
Swissmedic will communicate a timetable for the introduction of the medical devices database by the middle of this year.
All relevant specifications for stakeholders will be published on the Agency website as soon as they are available.
For more information, please visit Swissmedic website.
Meditrial is supporting medical device and IVD companies with regulatory compliance and market entry since 2008.
With offices in Europe (including Switzerland) and the US, Meditrial offers a wide range of market access services, including regulatory compliance, consulting, device registration, and in-country representation. Don’t hesitate to contact us!
Table of Contents
Getting a CE mark for medical devices: a step-by-step guide
Practical guidance on the CE mark for medical devices under EU MDR, from classification and evidence to conformity assessment and EUDAMED
A Practical RBQM Framework for Medical Device Trials
Risk-based quality management for medical device trials, with practical actions for risk assessment, monitoring, data review, and trial oversight
EU Breakthrough Medical Devices Under MDCG 2025-9 (BtX)
EU breakthrough medical devices gain a clearer regulatory pathway under MDCG 2025-9, with early advice and lifecycle evidence planning
What Swissmedic Fast-Track Means for Clinical Trial Sponsors
Swissmedic swissethics Fast-Track Pilot Project accelerates eligible trial reviews and makes coordinated regulatory preparation increasingly important.
FDA Breakthrough Device Acceleration
How innovative MedTech companies can accelerate FDA approval, secure Medicare coverage, and reach patients faster—starting with Breakthrough Device Designation.
The contribution of patient associations in clinical trials
Historically, patient organizations have had the primary purpose of supporting the communities they represented. Today, this remains a crucial function, but modes have changed, as has the role that associations and patients themselves take on [...]
This article provides general information and does not constitute regulatory or legal advice. Requirements should be confirmed for the specific study, applicable regulatory framework, and markets concerned.
